medicines australia
Investing in new medicines pays for itself: report
A new report has found that investing in new medicines pays for itself by reducing other public health expenditure. The modeling, published in The impact of pharmaceutical innovation on premature …
Medicines Australia chairman to step down
Dr Martin Cross, chairman of Medicines Australia, will retire from the Board upon the conclusion of the current Board term on 20 October 2015. Dr Cross was appointed to the …
High Court decision could undermine development of innovative medicines
The High Court decision to disallow patenting of isolated genetic materials is a worry for the innovative medicines sector, says Medicines Australia. “It is essential that Australia maintains strong and …
Medicines Australia disappointed by TPP outcomes
The outcomes of the negotiations for the Trans-Pacific Partnership agreed to in Atlanta overnight are a disappointing outcome and a missed opportunity to stimulate and grow the Australian biopharmaceutical industry, …
Medicines Australia 18th Code of Conduct comes into effect
The Guild and other health professional and consumer organisations have voiced their support for the transparency changes in the new Medicines Australia 18th Code of Conduct, which has come into …
PWC outlines medicines industry challenges: Medicines Australia
The 2015 PricewaterhouseCoopers survey of the Australian medicines industry provides an important and timely insight into the challenges and opportunities confronting the Australian innovative medicines industry, says Medicines Australia. The …
Policy keeping PBS spending in check: Medicines Australia
The release of the Final Budget Outcomes for 2014‑15 has revealed policy reforms are continuing to put downward pressure on PBS expenditure, says Medicines Australia. The final Budget papers released …
Health industry stakeholders welcome Ley, Nash, Wyatt
Health industry stakeholders continue to welcome the new Health team in the Turnbull ministry. The Australian Self Medication Industry today welcomed the new health team in the Turnbull Ministry: the …
‘A’ flagging has Medicines Australia concerned
Medicines Australia has expressed concern about the PBAC’s recommendation that pharmacists be allowed to substitute the biosimilars in place of biologic medicines prescribed by a patient’s doctor. “The so-called ‘a-flagging’ …
30% decline highlights pharma struggle: Medicines Australia
Australian medicines exports have declined by 30% in one year, and Medicines Australia says this highlights the enormous challenges facing the local industry as they struggle to remain competitive in …
Just the facts: Medicines Australia publishes meds trends book
A source of statistics and trends in the Australian and International medicines industry has been published in the latest edition of the Medicines Australia Facts Book (4th Edition). The findings …
MA urges Parliament on Medical Research Future Fund
Medicines Australia has tabled a submission urging the Parliament to pass legislation that will create the Medical Research Future Fund. However, if the MRFF is to succeed in addressing the …